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Only sparse and contradictory data are available on peripheral somatic nerve function in
relation to the total range of glucose tolerance. A random sample (n = 708) of people,
stratified by age, sex, and glucose tolerance, from a Caucasian population aged 50 to 74
years was invited to undergo an examination including measures of large-fibre nerve
function (ankle and knee reflexes, vibration sense, vibratory perception threshold (VPT)
at the foot) and one measure of small-fibre function (thermal discrimination threshold
(TDT) at the foot). A total of 267 subjects with a normal glucose tolerance (NGT), 167
with impaired glucose tolerance (IGT), 90 with newly diagnosed diabetes mellitus (NDM),
and 73 with previously known diabetes (KDM) were included. KDM was associated with
the highest prevalence of large-fibre nerve dysfunction. Within the range from NGT to
NDM, most large-fibre function measures showed a decline with decreasing glucose
tolerance. The TDT showed a decrease with an increase in fasting and post-load insulin
levels (p < 0.05). We conclude that glucose intolerance is associated with impaired
peripheral large-fibre nerve function, an association which seems to apply even in the
non-diabetic range. Higher insulin levels were associated with a better small-fibre
nerve function.
KEY WORDS Glucose tolerance	 Specific insulin Ankle tendon reflexes Quantitative
sensory testing Population-based survey Caucasians
Introduction
Diabetic neuropathy is most commonly a distal and
symmetrical polyneuropathy, involving a variable set of
somatic and autonomic nerve fibres. 1 ' 2 Its somatic
component may be manifested by pain, paresthesia,
cramps or muscle weakness, predominantly in the lower
limbs. It may also progress barely recognized by the
patient, playing nevertheless an important role in the
development of diabetic foot lesions, via loss of sensory
function and small muscle wasting. 3 Although distal
symmetrical polyneuropathy typically develops slowly
over many years, it may be the presenting feature of
diabetes in older patients45 and a number of studies
have shown that measurable deficits in peripheral somatic
nerve function may be present in subjects with newly
diagnosed non-insulin-dependent diabetes. 6- 1 ° It is not
known whether this early nerve dysfunction reflects a
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Abbreviations: NGT normal glucose tolerance, IGT impaired glucose
tolerance, NDM newly-diagnosed diabetes mellitus, KDM known
diabetes mellitus, OGTT oral glucose tolerance test, VPT vibratory
perception threshold, TDT temperature discrimination threshold, CI
confidence interval, OR odds ratio, IQD interquartile difference.
period of undiagnosed diabetes, or arises gradually
during a state of impaired glucose tolerance (IGT), prior
to the onset of diabetes. With respect to the risk of other
diabetes-related complications, such as cardiovascular
disease"-m and macro- and microproteinuria, 15 evidence
is accumulating for IGT to take an intermediate position
between normal glucose tolerance (NGT) and diabetes.
With respect to distal symmetrical polyneuropathy,
however, the few available studies have reported contra-
dictory results.' 6-18 Therefore we took the opportunity to
study, as part of an epidemiologic survey in a 50-74-
year-old general Caucasian population, the relation
between glucose tolerance and peripheral somatic nerve
function, across the total range of glucose tolerance,
from NGT to known diabetes. Peripheral nerve function
was assessed by examining the deep tendon reflexes of
the lower limbs and the vibration sensation at toes and
ankles. In addition, quantitative vibratory and thermal
sensory thresholds, indexing large and small-diameter
nerve fibre function, respectively, were measured at the
foot. Age, sex, body height, 18-2° alcohol intake, 21 and
smoking22 were considered as potentially confounding
factors. In the analyses with the sensory threshold data,
the skin temperature23 and the use of neuroleptic drugs
or benzodiazepines were also taken into account, the
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latter because of the possible adverse influence on the
concentration of the study subjects and, thus, on the
sensory threshold levels.
Subjects and Methods
Subjects
All study participants were members of the cohort of the
Hoorn Study, an epidemiologic survey on glucose
metabolism and related disorders in a general Caucasian
population. For this study, a random sample of 50-74-
year-old subjects was taken from the population register
of the town of Hoorn in the Netherlands. 24 All participants
not on oral hypoglycaemic agents or insulin treatment
underwent a 75 g oral glucose tolerance test (OGTT).25
Those with a 2-h post-load venous plasma glucose level
mmol I- 1 (n = 122), an 81 % (n = 254) sample from
the subjects with a 2-h post-load glucose --7.5 mmol I-1
and <11.1 mmol 1-1 , and a 13 % (n = 256) age and sex-
stratified random sample from those with a post-load
glucose <7.5 mmol I- 1 were invited to undergo a second
OGTT within 3 to 5 weeks. They were also asked to
participate in an examination concerning diabetes-related
disorders, as were the members of the Hoorn Study
cohort who were on oral hypoglycaemic agents or insulin
treatment for diagnosed diabetes mellitus (n = 76). Thus,
708 people in total were invited to take part in
the diabetes-related disorder study, which included an
assessment of peripheral somatic nerve function. Further
details on the sampling procedure are provided else-
where.26
The study protocol was approved by the Ethics
Committee of the Vrije Universiteit Academic Hospital.
Informed consent was given by all participants.
Physical Examination
Knee and ankle reflexes and vibration sensation at big
toes and medial malleoli (128 Hz tuning fork) were
classifed as present or absent in each participant by a
single observer, who was unaware of the glucose
tolerance status of the subjects. Bilateral absence was
considered to be a sign of distal symmetrical nerve dys-
function.
Sensory Threshold Tests -
Vibratory perception and thermal discrimination thresh-
olds were assessed, as described elsewhere. 27 Briefly,
the vibratory perception threshold (VPT) was assessed at
the dorsum of the right big toe by means of a Vibrameter
(Somedic, Stockholm, type IV) as the mean of 6 out of
10 ascending thresholds (in pcm vibratory amplitude),
excluding the two highest and the two lowest values.
The temperature discrimination threshold (TDT) was
assessed at the dorsum of the right foot, by means of a
two-alternative forced-choice testing procedure. Two
thermostimulators were applied, one after the other, on
the dorsum of the right foot, the temperature of the
second being set at random either higher or lower than
that of the first one. The subject was asked whether the
second stimulator was warmer or colder than the first
one, and the magnitude of the temperature difference
between the two was doubled or halved, depending on
the responses of the participant. The test was continued
until the course of the temperature difference showed
eight 'reversal points', and the TDT was then computed
as the mean temperature difference (in °C) at the last
six reversal points. All sensory thresholds were measured
by one of two observers, who used the same instruments
and were unaware of the glucose tolerance status of
the participants.
Parameters of Glucose Metabolism
Fasting and 2-h post-load venous plasma glucose levels
were determined with a glucose dehydrogenase method
(Merck, Darmstadt, Germany). Mean values of two
OGTTs, if available, were used in the data analysis.
HbAic and serum fructosamine were assessed once, by
ion-exchange high performance liquid chromatography
using a Modular Diabetes Monitoring System (Bio-Rad,
Veenendaal, NL, normal range 4.3-6.1 %), and by a
second generation serum fructosamine assay (Roche
Diagnostics, Basel, Switzerland), respectively.
Fasting and 2-h post-load specific serum insulin levels
were quantified (in duplicate for each OGTT) with
an insulin-specific double-antibody radioimmunoassay
(antibody: Linco SP21, St Louis, MO, USA). No cross-
reactivity with proinsulin and split proinsulin was found.
The intra-assay and inter-assay coefficient of variation
was 5-8 `)/0 and 7-11 %, respectively. Mean insulin
values were used in the data analysis.
In subjects treated with oral hypoglycaemic agents or
insulin, fasting plasma glucose and fasting serum insulin
(in duplicate) were measured on one occasion only.
These subjects were classified as having previously
known diabetes mellitus (KDM). All other participants
were classified, according to the World Health Organiza-
tion criteria 25,26 applied to the mean fasting and post-
load glucose values of two OGTTs, as having normal
glucose tolerance (NGT), impaired glucose tolerance
(IGT), or diabetes, either newly-diagnosed (NDM), or
KDM (the latter if they were previously diagnosed
as having diabetes, receiving dietary advice as their
only treatment).
Other Measurements
The medical history was obtained by means of a self-
administered questionnaire. 26 On their visit to the study
centre, the participants brought with them the completed
questionnaire and any drugs they were using. The names
of the drugs and the dosages prescribed were registered
from the labels on the packages. Subjects using phenytoin,
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or having a neurological disorder which could influence
peripheral somatic nerve function, were excluded from
the analysis. Questions on alcohol use and smoking
habits were incorporated in questionnaires designed
specifically for the study population at hand. A number
of variables representing different categorizations of
alcohol intake and smoking history were examined for
a possible confounding effect in the data analysis.
Analysis
The sensory threshold distributions were skewed and a
logarithmic transformation (log 10) was carried out to
obtain distributions which were close to normal, con-
ditionally on age, sex, and body height. Logistic regression
analysis was used to estimate odds ratio (with 95 °/0
confidence intervals (Os)) contrasting the (odds of the)
prevalences of signs of peripheral somatic dysfunction
at different levels of the independent variables. The
associations between parameters of glucose metabolism
(e.g. HbA, c) and sensory threshold levels (e.g. VPT) were
assessed by means of least squares regression analysis.
Regression models were fitted as follows:
log,o(VPT) = a +13,eHbA ic + b2.age
+ 133 esex + b4oheight + etc.
With these equations fitted to the data, the regression
coefficients can be interpreted (provided that the residuals
are normally distributed, which was checked in all
analyses), as the logarithms of the ratio of median values
or, briefly, the logarithms of median ratios, corresponding
to unit contrasts in the independent variables. 2 " All
parameters of glucose metabolism were expressed in
units which were equal to the difference between their
75th and 25th centile (the interquartile difference, IQD),
in order to be able to compare the magnitude of the
regression coefficients. Thus, the antilog of the coefficient
b, (10 01 ), for example, is equal to the median VPT in
subjects with HbA, c = x, + 1 .IQD, divided by the median
VPT in those with HbA, c = x,, adjusted for age and other
characteristics represented in the regression model. The
standard errors of the regression coefficients were used
to obtain the 95 % Cls of the median ratios.
In all regression analyses, age, sex, height, alcohol-
use, and smoking were considered as being characteristics
which could confound the relations at issue. The
skin temperature and the use of neuroleptic drugs or
benzodiazepines were regarded as potential confounders
only in the analyses with sensory threshold data.
Double-sided p values <0.05 were considered to be
statistically significant.
Results
Of the subjects invited to take part in the peripheral
nerve function assessment, 89 % (n = 631) participated.
The mean time which elapsed between the second
OGTT and the nerve function assessment was 54 days
(95th centile: 93 days). Thirty-three participants were
excluded because of histories of lumbar disc disease,
Parkinson's disease, cerebrovascular events, systemic
lupus erythematosus or spinal cord lesion. Also excluded
was one subject using phenytoin. Of the remaining 597
subjects, 267 had NGT, 167 had IGT, 90 had NDM,
and 73 had KDM, of whom 11 were treated by dietary
advice only (Table 1).
All subjects with KDM were older than 30 years of
age when diabetes was diagnosed, except for one woman
using insulin who was aged 29 at the time of diagnosis.
The median known duration of their diabetes was 6.6
years (5th and 95th centile: 1.0 and 25.9 years). Physical
examination data were missing for one subject, the VPT
for two, and the TDT for five subjects. For two persons,
the signs of polyneuropathy were scored as present on
those parts of the lower extremities which had been
amputated because of diabetic foot problems. With the
exception of the TDT, all measures of peripheral somatic
nerve function indicated a poorer function with reduced
glucose tolerance (Table 2).
Logistic regression analysis showed that, adjusting for
age, sex, and height, KDM was associated with the
highest prevalence of signs of peripheral nerve dysfunc-
tion (Table 3). The IGT and NDM categories showed a
smaller increase relative to NGT, which was statistically
significant only for the absence of ankle reflexes.
Excluding the subjects with KDM from the analysis, the
bilateral absence of vibration sensation at the big toes
and the absence of ankle and knee reflexes were
associated statistically significantly with various measures
of glycaemic level (Table 3). There were no significant
relations with fasting or post-load insulin levels (Table 3).
The odds ratios for the associations with the parameters
of glycaemia remained in the same order of magnitude
when only the subjects with NGT and IGT were included
in the analysis (data not shown). In this reduced
population, however, only the relation between post-load
glucose and absence of ankle reflexes was statistically
significant (OR = 2.4 (95 % CI: 1.4-4.2), p= 0.001). All
odds ratio estimates were influenced only marginally by
including in the regression model variables for smoking
and alcohol-intake (data not shown).
Adjusting for age, sex, and height by regression
analysis, the median VPT showed a statistically significant
increase relative to NGT in KDM, but not in IGT and
NDM (Table 4). The TDT was not significantly increased
in any of the glucose intolerance categories. In the
population without KDM, an increase in the parameters
of glycaemia equal to the interquartile difference was
accompanied by an increase in the medians of both
thresholds of about 5 %. However, only the association
between serum fructosamine and VPT was statistically
significant. Unlike the VPT, the median TDT showed a
10 % decrease with an IQD increase in fasting and post-
load insulin levels. The associations between fasting
glucose and insulin levels, on the one hand, and median
TDT on the other, did not change when glucose
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Table 1. Characteristics of study subjects according to categories of glucose tolerance
Normal glucose
tolerance
(n = 267)
I mpaired  glucose
tolerance
(n = 167)
Newly-diagnosed
diabetes mellitus
(n = 90)
Known diabetes
mellitus
(n = 73)
Sex (% men) 50 47 47 41
Age (yr) 63.3 ± 7.4 65.2	 6.9 65.9	 6.6 65.9	 6.8
Body height (cm) 168.8 ± 9.0 167.6 ± 8.9 166.7±9.0 167.9 ± 10.1
Fasting glucose (mmol 5.4 ± 0.5 6.1 ± 0.7 8.4± 3.1 10.5 ± 3.7
Post-load glucose (mmol I-1) 5.6	 1.3 9.1 ± 0.9 15.5 ± 5.7
HbA ic (%) 5.4 ± 0.5 5.6 ± 0.5 6.7	 1.9 7.7 ± 1.6
Serum fructosamine 240 ± 17 246 ± 19 284 ± 72 328	 66
Fasting insulin (pmol 73 (56, 93) 90 (68, 135) 116 (84, 157) 100 (73, 136)
Post-load insulin (pmol I-1) 302 (183, 420) 605 (377, 1050) 535 (277, 891)
Drinking --20 g alcohol day-1 17 12 18 17
Current cigarette smoking 30 24 21 25
Data expressed as percentage, mean ± SD, or median (25th, 75th centile).
'Not assessed in subjects treated with oral hypoglycaemic agents or insulin.
Table 2. Measures of peripheral somatic nerve function according to categories of glucose tolerance
Normal glucose
tolerance
(n = 267)
Impaired glucose
tolerance
(n = 167)
Newly diagnosed
diabetes mellitus
(n = 90)
Known diabetes
mellitus
(n = 73)
Vibration sensation (128 Hz) bilaterally
absent at
big toes	 28 27 39 50
medial malleoli	 5 5 7 8
Bilateral absence of
ankle reflexes
	
16 26 29 49
knee reflexes	 2 3 3 7
Vibratory perception threshold (ttm) 	 7.6 8.5 11.1 16.3
(3.8,	 19.7) (4.0,	 17.6) (4.1, 24.6) (7.2, 44.3)
Thermal discrimination threshold (° C)	 0.4 0.3 0.4 0.5
(0.2,	 0.7) (0.2,	 0.7) (0.2,	 0.7) (0.3,	 0.8)
Data expressed as percentage or median (25th, 75th centiles).
Table 3. Prevalence of signs of peripheral somatic dysfunction in relation to parameters of glucose metabolism: odds ratios
(with 95 % Cls) estimated by logistic regression analysis, adjusted for age, sex, and body height
Independent variable
Odds ratio for bilateral absence of
I nterquarti le
difference
Vibration sensation (128 Hz) at
big toes	 medial malleoli Ankle reflexes Knee reflexes
Glucose tolerance
IGT vs NGT 0.8 (0.5-1.3) 0.9 (0.4-2.2) 1.7" (1.1-2.8) 1.2 (0.4-4.1)
NDM vs NGT 1.5 (0.9-2.7) 1.1 (0.4-3.0) 2.0" (1.1-3.6) 1.3 (0.3-5.5)
KDM vs NGT 2.3' (1.3-4.2) 1.3 (0.5-3.8) 4.8" (2.7-8.6) 2.7 (0.8-9.3)
Fasting glucosea 1.1 mmol I-1 1.1 b (1.0-1.3) 1.1 (1.0-1.3) 1.1" (1.0-1.3) 1.2' (1.1-1.5)
Post-load glucosea 4.2 mmol I-1 1.2 (1.0-1.4) 1.1 (0.8-1.5) 1.4" (1.1-1.7) 1.4" (1.1-2.0)
HbAh_a 0.8 °/0 1.1 (1.0-1.4) 1.1 (0.9-1.4) 1.2` (1.1-1.4) 1.2 (0.9-1.5)
Serum fructosamine 27 p,mol 1- 1 1.2" (1.0-1.4) 1.1 (0.9-1.4) 1.1 (1.0-1.3) 1.2' (1.0-1.5)
Fasting insulina 52 pmol 1.1 (0.9-1.4) 1.2 (0.8-1.8) 1.2 (1.0-1.5) 1.2 (0.7-1.9)
Post-load insulina 423 pmol 0.9 (0.7-1.1) 0.7 (0.4-1.1) 1.1 (0.9-1.3) 1.0 (0.7-1.5)
NGT, normal glucose tolerance; IGT, impaired glucose tolerance; NDM, newly-diagnosed diabetes mellitus; KDM, known diabetes mellitus.
'Subjects with KDM excluded; odds ratios correspond to an increase in the independent variable equal to the interquartile difference;
by < 0.05; 'p < 0.01; `113 < 0.001.
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Table 4. Sensory thresholds in relation to parameters of glucose metabolism: median ratios (with 95 % Cls) estimated by regression
analysis, adjusted for age, sex, and body height
Independent variable
Median ratio
Interquartile difference
Vibratory perception
threshold
Thermal discrimination
threshold
Glucose tolerance
IGT vs NGT 0.97 (0.81-1.16) 0.90 (0.73-1.11)
NDM vs NGT 1.12 (0.89-1.41) 1.00 (0.77-1.30)
KDM vs NGT 1.63' (1.27-2.08) 1.17 (0.89-1.56)
Fasting glucose' 1.1 mmol 1.05 (0.99-1.11) 1.06 (1.00-1.12)
Post-load glucose' 4.2 mmol 1.06 (0.98-1.15) 1.02 (0.94-1.12)
HbAica 0.8 % 1.03 (0.97-1.10) 1.06 (0.98-1.14)
Serum fructosamine 27 limo! I-1 1.07" (1.01-1.14) 1.06 (0.99-1.14)
Fasting insulin' 52 pmol 1.07 (0.98-1.16) 0.90' (0.82-1.00)
Post-load insulin' 423 pmol 0.99 (0.92-1.06) 0.92' (0.85-0.99)
NGT, normal glucose tolerance; IGT, impaired glucose tolerance; NDM, newly diagnosed diabetes mellitus; KDM, known diabetes mellitus.
'Subjects with KDM excluded; median ratios correspond to an increase in the independent variable equal to the interquartile difference;
by
 < 0.05; `p < 0.001.
and insulin were entered into the regression model
simultaneously (Table 5). There was no indication of
the association between insulin levels and TDT being
dependent on the glucose level. When the subjects with
NDM were excluded from the analysis, the relation
between serum fructosamine and VPT was the only
one which remained statistically significant (median
ratio = 1.16 (95 % CI: 1.01-1.32), p = 0.03; other data
not shown). None of these analyses was more than
marginally influenced when variables were included for
smoking, alcohol-intake, skin temperature or use of
neuroleptic drugs or benzodiazepines (data not shown).
Discussion
Most measures of peripheral somatic dysfunction used
in our study clearly reflected the generally acknowledged
fact that subjects with non-insulin-dependent diabetes
mellitus are at an increased risk of a distal symmetrical
Table 5. Temperature discrimination threshold in relation to
fasting glucose and insulin levels, entered into the regression
model simultaneously: median ratios (with 95 % Cls), adjusted
for age, sex, and body height
Independent variable 	 Interquartile	 Median ratio
difference	 thermal
discrimination
threshold
Model 1
Fasting glucose'
	 1.1 mmol	 1.07' (1.01-1.14)
Fasting insulin' 	 52 pmol	 0.88' (0.80-0.98)
Model 2
Fasting glucose'
	 1.1 mmol 1- 1	 1.06 (1.00-1.12)
Post-load insulin'	 423 pmol I- 1 	0.92' (0.85-0.99)
'Subjects with known diabetes excluded; median ratios correspond to
an increase in the independent variable equal to the interquartile
difference; by < 0.05.
polyneuropathy. The most pronounced difference
between subjects with NGT and those with KDM was
found by means of a simple clinical test: the examination
of the Achilles tendon reflexes. Bilateral loss of ankle
jerks was also the only test which could detect statistically
significant differences between subjects with IGT or
NDM, and those with NGT. The absence of the 128 Hz
vibration sensation at the big toe and the loss of knee
reflexes, though not clearly more prevalent in the IGT
and NDM categories, nevertheless did show a decline
of nerve function with increasing glycaemic level,
measured on a continuous scale, within the range from
NGT to NDM. The same applied to the VPT at the big
toe. The relation between fructosamine and VPT in the
population including subjects with NGT and IGT only,
suggests that large-fibre sensory function starts to decline
in the range of non-diabetic glucose intolerance.
Our findings confirm other reports on peripheral
somatic nerve dysfunction in newly diagnosed non-
insulin-dependent diabetes. 6- 1 ° Contrary to another
study," our data suggest that some degree of nerve
dysfunction can be demonstrated already when diabetes
is detected by screening, rather than by clinical diagnosis.
The increased prevalence of the absence of ankle jerks
in subjects with IGT is in accordance with the results of
a previous study, based on a two-stage household
sampling procedure, in which, mainly on the basis of
bilateral abnormality of ankle reflexes, an odds ratio of
3.5 (95 % CI: 1.5-7.9) was found for the prevalence of
distal symmetrical polyneuropathy comparing IGT with
NGT. 17 ' 29 Other investigators, however, found IGT sub-
jects to be equal or even superior to NGT subjects with
respect to nerve conduction"' and sensory function.'
All nerve function measures which were included in this
study, are indices of large-fibre function, except for the
TDT. The TDT was also the only measure which was
associated with both fasting and post-load insulin levels:
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lower insulin levels were accompanied by a higher TDT.
This finding is consistent with experimental evidence
suggesting that C-peptide 3° or insulin-which shares
several molecular, structural, and physiological properties
with nerve growth factor 31 -may have direct beneficial
effects on nerve-tissue metabolism or function. In agree-
ment with this, a recent study showed that in subjects
with non-insulin-dependent diabetes mellitus, low serum
insulin concentrations were associated with the develop-
ment of polyneuropathy, regardless of the degree of
glycaemia. 32 The association between insulin and TDT
in our study suggests that in a population without known
diabetes, insulin or C-peptide may also have a subtle
beneficial effect on peripheral nerve function, which is
detectable in small nerve fibres only.
In conclusion, the results of this population-based
study show that glucose intolerance is associated with
an impaired peripheral somatic large-fibre nerve function,
an association which seems to apply even in the non-
diabetic range. As far as small nerve fibres are concerned,
the findings are consistent with the hypothesis that C-
peptide or insulin may have a beneficial effect on nerve-
tissue function.
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